Showing results (641-650 of 763) with videos related to

Sort By:
Pageof 77
Journal of the American Society of Nephrology : JASN|September 7, 2014
Paricalcitol for secondary hyperparathyroidism in renal transplantationMatias Trillini, Monica Cortinovis, Piero Ruggenenti, et al.
American Journal of Nephrology|December 15, 2017
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy TrialFinnian R Mc Causland, Brian Claggett, Marc A Pfeffer, et al.
Kidney International|December 20, 2016
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceTimothy H J Goodship, H Terence Cook, Fadi Fakhouri, et al.
Plos One|March 7, 2012
Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort studyPiero Ruggenenti, Flavio Gaspari, Antonio Cannata, et al.
Lancet (London, England)|June 4, 2013
Kidney failure: aims for the next 10 years and barriers to successGiuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.
Plos Medicine|June 24, 2021
Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trialPiero Ruggenenti, Paolo Cravedi, Eliana Gotti, et al.
Nephron|December 10, 2015
Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic NephropathyCarlamaria Zoja, Monica Locatelli, Daniela Corna, et al.
Immunobiology|September 18, 2020
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimabAlessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysisTazeen H Jafar, Christopher H Schmid, Paul C Stark, et al.
American Journal of Nephrology|January 17, 2015
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathyLuis M Ruilope, Rajiv Agarwal, Juliana C Chan, et al.
Pageof 77